1110020A21Rik Activators encompass a variety of chemical compounds that indirectly stimulate the functional activity of 1110020A21Rik through discrete signaling pathways. Compounds such as Forskolin and Ionomycin raise intracellular levels of cAMP and Ca2+, respectively, which are second messengers that activate protein kinases such as PKA or calcium-dependent signaling mechanisms. The phosphorylation events that follow can indirectly result in the enhanced activity of 1110020A21Rik by promoting signaling cascades that it is a part of. Similarly, PMA, through activation of PKC, may trigger a signaling cascade that intersects with that of 1110020A21Rik, leading to its increased functional activity. Lipid signaling molecules like Sphingosine-1-phosphate can engage sphingosine-1-phosphate receptors, initiating signaling events that amplify the functional role of 1110020A21Rik within its specific cellular context.
Further influence on 1110020A21Rik activity is exerted by kinase inhibitors, such as EGCG, Genistein, and the PI3K inhibitors LY294002 and Wortmannin, which by dampening competitive signaling pathways, may indirectly heighten the signaling processes involving 1110020A21Rik. Inhibitors targeting the MAPK pathway, including U0126 and SB203580, which specifically inhibit MEK1/2 and p38 MAPK, respectively, also modify the cellular signaling landscape in a manner that may favor the activation of 1110020A21Rik-associated pathways. A23187 further enhances 1110020A21Rik's activity by increasing intracellular calcium levels, thereby boosting calcium-dependent signaling pathways that 1110020A21Rik may be coupled with. Lastly, Staurosporine, despite its broad kinase inhibition profile, may indirectly foster the selective activation of 1110020A21Rik by mitigating the inhibitory effects exerted by specific kinases on the protein's related signaling processes. Collectively, these chemical activators, through their targeted influence on cellular signaling, facilitate the enhancement of 1110020A21Rik-mediated functions without necessitating upregulation of its expression or direct activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC). PKC phosphorylation can lead to the activation of proteins downstream or within the same pathway as 1110020A21Rik, thereby indirectly enhancing its functional activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
This lipid signaling molecule activates sphingosine-1-phosphate receptors, which can trigger intracellular signaling cascades that intersect with pathways involving 1110020A21Rik, potentiating its functional activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that elevates intracellular Ca2+ concentration, activating calcium-dependent proteins and pathways that may enhance the activity of 1110020A21Rik through downstream effects. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol that inhibits several kinases, potentially reducing competitive signaling and indirectly enhancing the pathways in which 1110020A21Rik is involved. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
As an inhibitor of PI3K, LY294002 can modulate downstream AKT signaling, potentially affecting pathways that regulate or interact with the functional activity of 1110020A21Rik. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAPK, which may lead to altered signaling in pathways that involve the regulation of 1110020A21Rik, indirectly increasing its activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts as a calcium ionophore, similar to Ionomycin, facilitating an increase in intracellular calcium levels and potentially enhancing signaling pathways that upregulate the activity of 1110020A21Rik. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor which may reduce competitive tyrosine kinase signaling, thus potentially enhancing pathways that upregulate 1110020A21Rik activity. | ||||||